The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 33 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Pyrroles  [Clear All Filters]
2013
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.. Curr Med Res Opin. 29(7), 791-2.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".. Dig Liver Dis. 45(1), 82-3.
Bamias, A., Tzannis K., Beuselinck B., Oudard S., Escudier B., Diosynopoulos D., et al. (2013).  Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.. Br J Cancer. 109(2), 332-41.
Kanaki, A. I., Sarafidis P. A., Georgianos P. I., Kanavos K., Tziolas I. M., Zebekakis P. E., et al. (2013).  Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.. Am J Hypertens. 26(5), 608-16.
Crown, J. P., Diéras V., Staroslawska E., Yardley D. A., Bachelot T., Davidson N., et al. (2013).  Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.. J Clin Oncol. 31(23), 2870-8.
2010
Kadoglou, N. P. E., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., & Liapis C. D. (2010).  Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.. J Vasc Surg. 51(1), 114-21.
Athyros, V. G., Tziomalos K., Karagiannis A., Wierzbicki A. S., & Mikhailidis D. P. (2010).  Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?. Curr Opin Cardiol. 25(4), 406-10.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Atorvastatin: safety and tolerability.. Expert Opin Drug Saf. 9(4), 667-74.
Kadoglou, N. P. E., Gerasimidis T., Kapelouzou A., Moumtzouoglou A., Avgerinos E. D., Kakisis J. D., et al. (2010).  Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.. Eur J Vasc Endovasc Surg. 39(3), 258-65.
Saratzis, A., Kitas G. D., Saratzis N., & Melas N. (2010).  Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.. Angiology. 61(2), 137-44.
Fountzilas, G., Fragkoulidi A., Kalogera-Fountzila A., Nikolaidou M., Bobos M., Calderaro J., et al. (2010).  A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.. Cancer Chemother Pharmacol. 65(4), 649-60.
Bamias, A., Karadimou A., Lampaki S., Lainakis G., Malettou L., Timotheadou E., et al. (2010).  Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model.. BMC Cancer. 10, 45.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.